Content about Collaborative Care

April 14, 2014

Dietary supplement use by U.S. adults is more prevalent than indicated by published data from the National Health and Nutrition Examination Surveys, according to a new article in the peer-reviewed Journal of the American College of Nutrition.

WASHINGTON — Dietary supplement use by U.S. adults is more prevalent than indicated by published data from the National Health and Nutrition Examination Surveys, according to a new article in the peer-reviewed Journal of the American College of Nutrition. The review article is based on five consecutive years of online market research studies, conducted by Ipsos Public Affairs for the Council for Responsible Nutrition.

April 14, 2014

QS/1, a provider of healthcare automation solutions, announced the introduction of the Motion SlateMate tablet, a wireless device that is available for use with QS/1's pharmacy management systems and point-of-sale platforms.

SPARTANBURG, S.C. — QS/1, a provider of healthcare automation solutions, announced the introduction of the Motion SlateMate tablet, a wireless device that is available for use with QS/1's pharmacy management systems and point-of-sale platforms.

April 14, 2014

Retail clinic operator RediClinic has formed a joint venture with Seton Healthcare Family to expand the number of RediClinics operating in H-E-B stores in the Austin, Texas area.

AUSTIN, Texas — Retail clinic operator RediClinic has formed a joint venture with Seton Healthcare Family to expand the number of RediClinics operating in H-E-B stores in the Austin, Texas area.

“We are very excited about our new partnership with Seton because it will enable us to expand our service in the Austin community,” said Web Golinkin, RediClinic’s CEO. “This means at least doubling the number of clinics we operate in Austin and collaborating with Seton to ensure continuity of care for RediClinic patients.”

April 14, 2014

ShopRite is planning to open a pharmacy inside the Doylestown Hospital on June 1, marking its first location inside a medical facility.

DOYLESTOWN, Pa. — ShopRite is planning to open a pharmacy inside the Doylestown Hospital on June 1, marking its first location inside a medical facility.

“We are looking forward to working with the hospital to make access to medications and medical supplies convenient for all patients,” said Joe Cowhey, president of the Cowhey Family Supermarket, a family business that owns and operates the ShopRite of Warminster.

April 14, 2014

Stayhealthy has announced the completion of its deployment of 765 Stayhealthy HealthCenter Kiosks throughout Albertson’s LLC and New Albertson’s Inc.

MONROVIA, Calif. — Stayhealthy has announced the completion of its deployment of 765 Stayhealthy HealthCenter Kiosks throughout Albertson’s LLC and New Albertson’s Inc.

April 11, 2014

Mylan on Friday confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an abbreviated new drug application with the Food and Drug Administration for frovatriptan succinate tablets, 2.5 mg.

PITTSBURGH — Mylan on Friday confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an abbreviated new drug application with the Food and Drug Administration for frovatriptan succinate tablets, 2.5 mg. This product is the generic version of Frova, which is used to treat acute migraine headaches in adults. 

April 11, 2014

NCPDP, the not-for-profit pharmacy standards development organization, on Wednesday announced the availability of a patient safety white paper that provides specific industry guidance for standardizing the dosing designations and labeling of oral liquid medications.

SCOTTSDALE, Ariz. — NCPDP, the not-for-profit pharmacy standards development organization, on Wednesday announced the availability of a patient safety white paper that provides specific industry guidance for standardizing the dosing designations and labeling of oral liquid medications. 

April 11, 2014

The New York State legislature recently wrapped up its 2015 budget negotiations with a favorable outcome for community pharmacy as it rejected an executive branch proposal to change how New York’s Medicaid program reimburses pharmacies for prescription medications.

WASHINGTON — The New York State legislature recently wrapped up its 2015 budget negotiations with a favorable outcome for community pharmacy: It rejected an executive branch proposal to change how New York’s Medicaid program reimburses pharmacies for prescription medications.

If enacted, the proposal would have cut payments to pharmacies by $82 million annually, according to estimates, by setting the price for drugs based on a three-month rolling average acquisition cost.

April 10, 2014

Prescription drug trend grew 3.8% in 2013, driven by significant price inflation for traditional brand drugs, specialty drugs and generics, as well as an increase in utilization as members filled more prescriptions in the slowly improving economy, according to the findings of CVS Caremark’s annual "Insights" report released on Thursday.

WOONSOCKET, R.I. — Prescription drug trend grew 3.8% in 2013, driven by significant price inflation for traditional brand drugs, specialty drugs and generics, as well as an increase in utilization as members filled more prescriptions in the slowly improving economy, according to the findings of CVS Caremark’s annual "Insights" report released on Thursday. This compares with 2012, which experienced nearly flat growth at 0.1%.

April 10, 2014

Lupin announced that it received final approval from the Food and Drug Administration for pioglitazone tablets USP in 15-mg, 30-mg and 45-mg strengths.

MUMBAI and BALTIMORE — Lupin announced that it received final approval from the Food and Drug Administration for pioglitazone tablets USP in 15-mg, 30-mg and 45-mg strengths. The product is the generic version of Actos tablets from Takeda Pharmaceuticals.

The drug is used an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes. Actos tablets had annual sales in the United States of approximately $236 million as of December 2013, according to IMS MAT data. 

 

April 10, 2014

Rite Aid on Thursday announced it has acquired Houston-based RediClinic, one of the nation’s leading operators of retail clinics.

CAMP HILL, Pa. — Rite Aid on Thursday announced it has acquired Houston-based RediClinic, one of the nation’s leading operators of retail clinics. RediClinic currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Through the acquisition, RediClinic will operate as a wholly owned subsidiary of Rite Aid. 

Details of the transaction were not disclosed.

April 9, 2014

Emphasizing implementation challenges that could impact patient access to pharmacy services, a coalition is urging Secretary of Health and Human Services Secretary Kathleen Sebelius to allow a one-year transition period for states to fully implement the Medicaid average manufacturer’s price-based federal upper limits for prescription medications.

ARLINGTON, Va. — Emphasizing implementation challenges that could impact patient access to pharmacy services, a coalition is urging Secretary of Health and Human Services Secretary Kathleen Sebelius to allow a one-year transition period for states to fully implement the Medicaid average manufacturer’s price-based federal upper limits for prescription medications.

April 9, 2014

Herb Pharm recently debuted a new logo and label design across its entire product line in conjunction with the launch of three new herbal supplements — Inflamma Response capsules, Passionflower capsules and Turmeric softgels.

WILLIAMS, Ore. — Herb Pharm recently debuted a new logo and label design across its entire product line in conjunction with the launch of three new herbal supplements — Inflamma Response capsules, Passionflower capsules and Turmeric softgels.

The new scheme makes use of color-coded functional categories that are easy to spot and understand. The new color-coded system enables retailers to merchandise products by category, while also providing consumers an at-a-glance reference point intended to educate, facilitate product selection and eliminate confusion. 

April 9, 2014

Omnis Health on Tuesday announced the launch of EmbracePro, a blood-glucose meter for medical professionals.

NASHVILLE, Tenn. — Omnis Health on Tuesday announced the launch of EmbracePro, a blood-glucose meter for medical professionals. Approved for multi-patient use, EmbracePro features a test strip release button for more hygienic strip disposal and provides accurate results within five seconds. 

April 9, 2014

As the cost for specialty medications continues to rise, implementing an effective "channel transition" approach — the process of moving prescriptions from the medical benefit to the pharmacy benefit — can produce significant savings for healthcare payers by improving management of these complex and costly drugs, according to a new report commissioned by CVS Caremark.

WOONSOCKET, R.I. — As the cost for specialty medications continues to rise, implementing an effective "channel transition" approach — the process of moving prescriptions from the medical benefit to the pharmacy benefit — can produce significant savings for healthcare payers by improving management of these complex and costly drugs, according to a new report commissioned by CVS Caremark.

April 9, 2014

According to new survey data recently released by the National Consumers League, one-third of adult Americans still believe that vaccines may be linked to autism in children.

WASHINGTON — According to new survey data recently released by the National Consumers League, one-third of adult Americans still believe that vaccines may be linked to autism in children. According to the survey, 33% of parents of children under the age of 18 and 29% of all adults continue to believe “vaccinations can cause autism.” Scientific studies have clarified that use of vaccines is not linked to autism in children, the NCL noted. 

April 9, 2014

The Consumer Healthcare Products Association on Tuesday applauded Tennessee state Rep. Tony Shipley, R-Kingsport, after his legislation — H.B. 1257 — passed out of the Tennessee House of Representatives.

WASHINGTON — The Consumer Healthcare Products Association on Tuesday applauded Tennessee state Rep. Tony Shipley, R-Kingsport, after his legislation — H.B. 1257 — passed out of the Tennessee House of Representatives. The bill, which passed the Senate last week, would implement a real-time, drug offender block list in Tennessee. 

The measure now heads to Tennessee Gov. Bill Haslam for his signature.

April 8, 2014

Diplomat on Monday announced that it is one of a select group of specialty pharmacies contracted by Celgene to distribute Otezla (apremilast), a new medication for the treatment of psoriatic arthritis.

FLINT, Mich. — Diplomat on Monday announced that it is one of a select group of specialty pharmacies contracted by Celgene to distribute Otezla (apremilast), a new medication for the treatment of psoriatic arthritis. Otezla is an oral small-molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAMP). 

Otezla was approved by the FDA on March 21, 2014, and is available in 10 mg, 20 mg and 30 mg tablets. 

April 8, 2014

Healthcare Distribution Management Association president and CEO John Gray on Monday testified before the House Energy and Commerce Subcommittee on Health at a hearing on “Improving Predictability and Transparency in DEA and FDA Regulation.”

ARLINGTON, Va. — Healthcare Distribution Management Association president and CEO John Gray on Monday testified before the House Energy and Commerce Subcommittee on Health at a hearing on “Improving Predictability and Transparency in DEA and FDA Regulation.” HDMA is in support of the Ensuring Patient Access and Effective Drug Enforcement Act of 2014, H.R. 4069, sponsored by Reps. Marino, R-Pa., and Blackburn, R-Tenn. 

April 8, 2014

Sunovion Pharmaceuticals on Monday announced that Aptiom (eslicarbazepine acetate), a once-daily antiepileptic drug, is now available across the United States.

MARLBOROUGH, Mass. — Sunovion Pharmaceuticals on Monday announced that Aptiom (eslicarbazepine acetate), a once-daily antiepileptic drug, is now available across the United States.

The drug, which received approval from the Food and Drug Administration on Nov. 8, 2013, is a prescription medicine used with other medicines to treat partial-onset seizures. The drug is available in four table strengths: 200 mg, 400 mg, 600 mg and 800 mg; it can be taken whole or crushed, with food or without.

April 8, 2014

Teva Pharmaceutical Industries announced that it has received approval from the Food and Drug Administration for its generic form of Lovaza (omega-3-acid ethyl esters capsules, USP) in the United States.

JERUSALEM — Teva Pharmaceutical Industries announced that it has received approval from the Food and Drug Administration for its generic form of Lovaza (omega-3-acid ethyl esters capsules, USP) in the United States.

Lovaza is used as an adjunct to diet to reduce triglycerdide levels in adult patients, according to the FDA. Teva believes it is the first to file and plans to begin shipping immediately.

Lovaza capsules, marketed by GlaxoSmithKline, had annual sales of $1.1 billion in the United States as of December 2013, according to IMS data.

 

April 8, 2014

Upsher-Smith has announced the release of the first in a series of educational e-books authored by Hamacher Resource Group and created for independent community pharmacists.

WAUKESHA, Wis. — Upsher-Smith has announced the release of the first in a series of educational e-books authored by Hamacher Resource Group and created for independent community pharmacists.

The first e-book in the series is “Community Pharmacy: Foundation for the Future,” and was developed to assist independent pharmacists/owners with assessing the state of their business and preparing strategies for continued growth.

April 7, 2014

Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration has approved Pradaxa (dabigatran etexilate mesylate), which is used to treat deep venous thrombosis and pulmonary embolism.

RIDGEFIELD, Conn. — Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration has approved Pradaxa (dabigatran etexilate mesylate). The drug is indicated for the treatment of deep venous thrombosis and pulmonary embolism in patients who have received a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated, the company said.

April 7, 2014

Mallinckrodt and Questcor Pharmaceuticals on Monday announced that they have entered into a definitive merger agreement under which Mallinckrodt will acquire Questcor in a transaction valued at approximately $5.6 billion.

DUBLIN — Mallinckrodt and Questcor Pharmaceuticals on Monday announced that they have entered into a definitive merger agreement under which Mallinckrodt will acquire Questcor in a transaction valued at approximately $5.6 billion. The transaction was unanimously approved by the boards of directors of both companies. Subject to customary closing conditions, the transaction currently is expected to be completed in the third calendar-quarter of 2014.

April 7, 2014

McKesson on Monday announced that the results of the initial acceptance period of the voluntary public takeover offer for the remaining shares of Celesio AG have been published.

SAN FRANCISCO — McKesson on Monday announced that the results of the initial acceptance period of the voluntary public takeover offer for the remaining shares of Celesio AG have been published. 

McKesson now owns 75.7% of Celesio shares on a fully diluted basis.

Shareholders who did not tender their Celesio shares into the takeover offer during the initial acceptance period may tender their shares within the additional two-week acceptance period. The additional two-week acceptance period will begin on April 8 and will expire on April 22.